Leptin, a hormone secreted by fat cells (1-3), mediates central hormonal and metabolic responses to nutritional status by binding and activating the long form of the leptin receptor (LRb) 1 in the hypothalamus (4). Alternate splicing of the LR primary transcript results in the production of multiple isoforms (LRa to -e) that contain a common extracellular domain (5-7). While most LR isoforms possess a short 32-40-amino acid intracellular tail, LRb contains a unique approximately 300-amino acid intracellular tail that is required for the normal regulation of energy balance and endocrine function (5-14).LRb is a member of the interleukin-6 receptor family of class I cytokine receptors (9,(15)(16)(17). Ligand binding to LRb results in the activation and tyrosine phosphorylation of Jak2 and the subsequent tyrosine phosphorylation of Tyr 985 and Tyr 1138 of LRb (18 -21). Tyrosine phosphorylation of cytokine and growth factor receptors activates intracellular signals by recruiting specific signaling proteins with specialized phosphotyrosinebinding domains, such as Src homology 2 (SH2) domains (22). The SH2 domain isoforms of different signaling proteins bind phosphotyrosine in the context of unique amino acid motifs; thus, each tyrosine phosphorylation site recruits specific downstream signaling proteins based on its surrounding amino acids. Phosphorylated Tyr 1138 of LRb recruits the SH2 domaincontaining transcription factor STAT3, resulting in the tyrosine phosphorylation of STAT3 and its translocation to the nucleus (17, 21,(23)(24)(25). Once in the nucleus, STAT3 mediates gene transcription, including transcription of the suppressor of cytokine signaling, SOCS3 (21, 26). Phosphorylated Tyr 985 of LRb recruits the SH2 domain-containing protein-tyrosine phosphatase SHP-2 (21, 27, 28). We have previously shown that Tyr 985 regulates ERK activation and c-fos transcription in cultured cells but does not alter phosphorylation of Jak2 or STAT3 during brief ligand stimulation (21). Others have suggested that Tyr 985 , by recruiting the tyrosine phosphatase SHP-2, may mediate dephosphorylation of LRb and Jak2, thereby attenuating LRb signaling (27,28).Mutations that disrupt leptin in rodents and humans result in morbid obesity and endocrine dysfunction (4, 29). Leptin levels are very high in obese humans, suggesting the presence of leptin resistance (4, 30). Human obesity/leptin resistance rarely results from genetic disruption of LRb (31), suggesting that other factors must mediate leptin resistance. A number of potential mechanisms for physiologic leptin resistance have been proposed, including saturation of a transport mechanism across the blood-brain barrier and the presence of biochemical inhibitors of LRb signaling, including SHP-2 and SOCS3 (4, 26 -28, 32-35).SOCS3 (also known as CIS3) is an SH2 domain-containing protein that inhibits signaling by certain cytokine receptor-Jak kinase complexes, either by directly inhibiting Jak2 activity or by targeting the complex to the proteosome (36). Leptin treatment induces...